AChE/MAO-IN-1 is a potent triple-target inhibitor, effectively blocking human acetylcholinesterase (AChE), MAO-A, and MAO-B with IC50 values in the nanomolar range. This profile makes it a valuable research tool for investigating neurodegenerative disease mechanisms and potential therapeutic strategies in both cellular and animal models.